Bett 0.5ml Injection

Bett 0.5ml Injection is an adsorbed tetanus vaccine indicated for active immunization against tetanus. This vaccine is formulated for use in adults, children, and infants 6 weeks of age or older to prevent tetanus, also known as lockjaw. It is also utilized for post-exposure prophylaxis of tetanus, neonatal tetanus prevention, and tetanus prophylaxis in wound management.

Manufactured by Biological E. Limited, Bett 0.5ml Injection contains Tetanus Toxoid (≥ 40 IU) adsorbed on Aluminium Phosphate (≥ 1.5 mg) per 0.5ml dose. The vaccine is administered intramuscularly, preferably into the deltoid muscle region of the upper arm. It is crucial to shake the vaccine vigorously before use to ensure the suspension is homogenized.

Key Features : 

Antigen Composition: Contains Tetanus Toxoid (≥ 40 IU) adsorbed on Aluminium Phosphate (≥ 1.5 mg) per 0.5ml dose.
Approved Indications and Target Population: Indicated for active immunization against tetanus in individuals 6 weeks of age or older, post-exposure prophylaxis, neonatal tetanus prevention, and tetanus prophylaxis in wound management.
Cold-chain Storage Temperature: Requires storage between +2°C to +8°C, must not be frozen, and should be protected from light.
Regulatory Approval: Manufactured by Biological E. Limited, this vaccine meets the requirements of WHO and BP, is WHO pre-qualified, and approved by CDSCO.
Route of Administration: Administered via intramuscular (IM) injection.
Reconstitution Requirements: Requires vigorous shaking before use to homogenize the suspension.